Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency
MONDO:0008729Congenital adrenal hyperplasia due to 11 beta-hydroxylase (CYP11B1) deficiency is a rare form of congenital adrenal hyperplasia (CAH) characterized by glucocorticoid deficiency, hyperandrogenism, hypertension and virilization in females.
Also known as: CAH due to 11-beta-hydroxylase deficiency, CYP11B1 deficiency, adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 11-Beta-Hydroxylase deficiency, P450C11B1 deficiency, adrenal hyperplasia 4, adrenal hyperplasia IV, adrenal hyperplasia hypertensive form
3 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Researchers launch major study to unravel mysteries of excess male hormones
Knowledge-focused Recruiting nowThis natural history study aims to gather information from up to 3,000 people with genetic conditions that cause too much androgen (male-like hormones), such as congenital adrenal hyperplasia (CAH) and familial male-limited precocious puberty (FMPP). Participants undergo various …
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
New imaging tracer could shed light on adrenal cholesterol
Knowledge-focused Recruiting nowThis study tests a special radioactive tracer called [18F]FNP-59 to see if it can safely and clearly show cholesterol activity in the adrenal gland using PET scans. About 24 people will take part, including healthy volunteers and those with known adrenal problems. The goal is to …
Phase: EARLY_PHASE1 • Sponsor: Benjamin Viglianti • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC